Efficacy of a novel cytotoxic polybisphosphonate for treatment of bone metastasis in castration-resistant prostate cancer (CRPC). This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results